Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer

Identification and validation of a five-lncRNA signature for predicting survival with targeted drug candidates in ovarian cancer

The dysregulation of long non-coding RNAs (lncRNAs) plays a crucial role in ovarian cancer (OC). In this study, we screened out five differentially expressed lncRNAs (AC092718.4, AC138035.1, BMPR1B-DT, RNF157-AS1, and TPT1-AS1) between OC and normal ovarian based on TCGA and GTEx RNA-seq databases b...

Full description

Bibliographic Details
Main Authors: Nuan Lin, Jia-zhe Lin, Yoshiaki Tanaka, Pingnan Sun, Xiaoling Zhou
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Bioengineered
Subjects:
ovarian cancer
risk signature
long non-coding rnas
small molecular drugs
computational biology
Online Access:http://dx.doi.org/10.1080/21655979.2021.1946632

Internet

http://dx.doi.org/10.1080/21655979.2021.1946632

Similar Items